Long-term postresection prognosis of primary neuroendocrine tumors of the liver

다국어 초록 (Multilingual Abstract)

Purpose: Primary hepatic neuroendocrine tumor (PHNET) is a very rare neoplasm, requiring strict exclusion of metastasis from possible extrahepatic primary sites for its diagnosis.
Methods: We reviewed our clinical experience of 13 patients with primary hepatic NET who underwent liver resection from January 1997 to December 2015.
Results: The mean age of the 13 patients (8 males and 5 females) was 51.1 ± 12.8 years; the most common clinical manifestation was vague, nonspecific abdominal pain (n = 9). Of them, 11 patients underwent preoperative liver biopsy, 7 of which correctly diagnosed as neuroendocrine tumor (NET). Ten patients underwent R0 resection, and 3 underwent R1 resection. Diagnosis of PHNET was confirmed both immunohistochemically and by absence of extrahepatic primary sites.
All tumors were single lesions, with a mean size of 9.6 ± 7.6 cm and a median size of 4.3 cm; all showed positive staining for synaptophysin and chromogranin. During a mean follow-up period of 95.1 ± 86.6 months, 7 patients died from tumor recurrence, whereas the other 6 remain alive to date, making the 5-year tumor recurrence rate 56.0% and the 5-year patient survival rate 61.5%. When confined to R0 resection, 5-year recurrence and survival rates were 42.9% and 70.0%, respectively. Univariate analysis showed that Ki-67 proliferative index was the only risk factor for tumor recurrence.
Conclusion: PHNET is a very rare tumor with no specific clinical features, and its final diagnosis depends primarily on pathology, immunohistochemistry, and exclusion of metastasis from other sites. Aggressive surgical treatment is highly recommended for PHNET because of acceptably favorable postresection outcomes

참고문헌 (Reference)

1 Kress O, "Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors--a retrospective single-center analysis" 68 : 94-101, 2003

2 Kim JE, "Three-phase helical computed tomographic findings of hepatic neuroendocrine tumors : pathologic correlation with revised WHO classification" 35 : 697-702, 2011

3 Hwang S, "Surgical treatment of primary neuroendocrine tumors of the liver" 12 : 725-730, 2008

4 Bahra M, "Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas" 22 : 930-935, 2007

5 Le Treut YP, "Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report" 225 : 355-364, 1997

6 Varker KA, "Repeat transarterial chemoembolization(TACE)for progressive hepatic carcinoid metastases provides results similar to first TACE" 11 : 1680-1685, 2007

7 Sophie Gabriel, "Prospective evaluation of 68 Ga-DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkers" Wiley 89 (89): 155-163, 2018

8 Wang LX, "Primary hepatic neuroendocrine tumors : comparing CT and MRI features with pathology" 15 : 13-, 2015

9 Yang K, "Primary hepatic neuroendocrine tumor with multiple liver metastases : a case report with review of the literature" 21 : 3132-3138, 2015

10 Yalav O, "Primary hepatic neuroendocrine tumor : five cases with different preoperative diagnoses" 23 : 272-278, 2012

11 Shetty PK, "Primary hepatic neuroendocrine tumor : an unusual cystic presentation" 53 : 760-762, 2010

12 Huang YQ, "Primary hepatic neuroendocrine carcinoma : clinical analysis of 11 cases" 9 : 44-48, 2010

13 Li RK, "Primary hepatic neuroendocrine carcinoma : MR imaging findings including preliminary observation on diffusion-weighted imaging" 38 : 1269-1276, 2013

14 Zhang A, "Primary hepatic carcinoid tumours : clinical features with an emphasis on carcinoid syndrome and recurrence" 36 : 848-859, 2008

15 Rocca A, "Primary giant hepatic neuroendocrine carcinoma: a case report" 12 (12): S218-S221, 2014

16 Krishnamurthy SC, "Primary carcinoid tumor of the liver : report of four resected cases including one with gastrin production" 62 : 218-221, 1996

17 Oberg K, "Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours" 19 : 265-276, 2005

18 Oberg K, "Neuroendocrine gastrointestinal tumors--a condensed overview of diagnosis and treatment" 10 (10): S3-S8, 1999

19 Knox CD, "Long-term survival after resection for primary hepatic carcinoid tumor" 10 : 1171-1175, 2003

20 Lehnert T, "Liver transplantation for metastatic neuroendocrine carcinoma : an analysis of 103 patients" 66 : 1307-1312, 1998

21 Brown DC, "Ki67 protein : the immaculate deception" 40 : 2-11, 2002

22 Fenwick SW, "Hepatic resection and transplantation for primary carcinoid tumors of the liver" 239 : 210-219, 2004

23 Oberg K, "Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors" 67 (67): 109-112, 2012

24 Kellock T, "Diagnostic imaging of primary hepatic neuroendocrine tumors : a case and discussion of the literature" 2014 : 156491-, 2014

25 Qiu MJ, "Comparative clinical analysis of gastroenteropancreatic neuroendocrine carcinomas with liver metastasis and primary hepatic neuroendocrine carcinomas" 2018 : 9191639-, 2018

26 Creutzfeldt W, "Carcinoids and carcinoid syndrome" 82 (82): 4-16, 1987

27 Caplin ME, "Carcinoid tumour" 352 : 799-805, 1998

28 Godwin JD 2nd, "Carcinoid tumors. An analysis of 2,837 cases" 36 : 560-569, 1975

29 Modlin IM, "An analysis of 8305 cases of carcinoid tumors" 79 : 813-829, 1997